Executive EHS at Acadia Pharmaceuticals

Hyderabad, Telangana, India

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

B.Tech in engineering or M.Sc in Chemistry & SBTET Approved Industrial Safety Diploma
6-8 years of pharma experience
Good knowledge on operational/process safety related activities
Good knowledge on ESG & Sustainable practices
Good knowledge on ETP Compliances like CFE, CFO, monthly, half yearly returns, Form IV & V etc

Responsibilities

Regular site rounds and identification of unsafe acts/conditions & its reporting
Implementation of all EHS Policies, Procedures & Work Instructions
Constant vigilance to comply the work permit system (all types of permits)
Conduct the EHS Induction trainings for all new joiners (shop floor) in the site
Conduct the EHS Trainings/toolbox talks for shopfloor employees/workmen
Coordination for the employee Annual Health checkups
Random checking for the working condition of all Emergency Equipment's
Responsible to fulfil the CFT’s EHS requirements on need basis
Responsible to track the Safety Gemba walk observations & its closures
Responsible to track the safety committee action items closures
Focus on target to achieve the zero incident milestones
Coordination for IMS Documentation activities (including CFT’s)
Indenting & procurement of safety materials to the CFT’s (PPE’s) on need basis
Coordination for emergency evacuation drills & fire drills as per the schedules
Implement the site EHS policies and procedural instructions
Participate in all site EHS activities in the absence of EHS Lead
Implement & follow the site EHS Lead Instructions
Preparation of new SOP's and internal audits etc

Skills

EHS Policies

Work Permit System

EHS Training

Safety Audits

Emergency Drills

PPE Procurement

IMS Documentation

SOP Preparation

Internal Audits

Process Safety

ESG Practices

ETP Compliance

Safety Gemba Walks

Health Checkups

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free